Advertisement
Advertisement

NMRA

NMRA logo

Neumora Therapeutics, Inc. Common Stock

2.19
USD
Sponsored
+0.04
+1.86%
Apr 20, 15:58 UTC -4
Closed
exchange

After-Market

2.35

+0.16
+7.08%

Neumora Therapeutics, Inc. Common Stock Profile

About

Neumora Therapeutics Inc. is a clinical-stage biopharmaceutical company. Its therapeutic pipeline currently consists of clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Neumora Therapeutics Inc. is based in WATERTOWN, Mass.

Info & Links

CEO

Paul L. Berns

Headquarters

260 ARSENAL PLACE, SUITE 1
WATERTOWN, MA 02472, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.neumoratx.com

Auditor

Ernst & Young LLP

Share holders

78

Employees

96

Neumora Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

426.89M

Enterprise Value

298.89M

Enterprise Value/EBITDA(ttm)

-1.23

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

3.35

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-146.41%

Return on Invested Capital(ttm)

-130.77%

Return on Assets(ttm)

-111.57%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-242.67M

Net Income Available to Common(ttm)

-236.93M

Diluted EPS(ttm)

-1.45

Share Statistics

Beta (5Y Monthly)

3.08

52-Week Change

238.59%

S&P 500 52-Week Change

37.82%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

182.04M

Dividend Yield

0.00%

Float4

133.25M

% Held by Insiders

26.80%

% Held by Institutions

47.65%

Balance Sheet

Total Cash(mrq)

182.53M

Total Cash Per Share(mrq)

1.00

Total Debt(mrq)

54.53M

Total Debt/Equity(mrq)

52.50%

Current Ratio(mrq)

5.87%

Quick Ratio(mrq)

5.87%

Book Value Per Share(mrq)

0.60

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.26

Free Cash Flow(ytd)

-206.22M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement